Literature DB >> 4081544

Characterization of potentially man-infective Trypanosoma brucei from an endemic area of sleeping sickness in Kenya.

L H Otieno, N Darji.   

Abstract

Human trypanosomiasis caused by Trypanosoma brucei rhodesiense has affected the human population in Lambwe Valley, western Kenya, for more than 20 years. A characteristic feature of the disease has been the repeated recrudescense at restricted residual foci. Studies carried out on the incidence of trypanosome infection rates in the vector Glossina pallidipes during the last two years have shown high incidence of pathogenic African trypanosomes in the area. An overall trypanosome infection rate of 18.6% was recorded. T. vivax accounted for 15% of all infected flies whereas T. congolense was detected in 2.7% of flies examined. T. brucei infections were observed in 0.9% of the flies. Twenty-six T. brucei isolates were tested for their sensitivity to human plasma using Blood Incubation Infectivity Test (BIIT), and 14 (54%) gave positive BIIT reactions. Isoenzyme characterisation of all BIIT positive isolates was carried out in order to detect any variations within these potentially man-infective T. brucei. Of the seven zymodemes observed, two were more frequently represented. Zymodeme (Z1) was represented by five stocks. This zymodeme was completely identical electrophoretically to T.b. rhodesiense isolated from patients in the same locality. Zymodeme (Z4) was represented by four stocks. This zymodeme does not have the ALAT I in combination with PGM II and ICD II patterns which are characteristic of typical West African T.b. gambiense. The high frequency of PGM III and ICD III strongly suggested the occurrence of hybridization of zymodemes in the area.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4081544

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  2 in total

1.  History of sleeping sickness in East Africa.

Authors:  G Hide
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

2.  Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model.

Authors:  Kariuki Ndung'u; Grace Adira Murilla; John Kibuthu Thuita; Geoffrey Njuguna Ngae; Joanna Eseri Auma; Purity Kaari Gitonga; Daniel Kahiga Thungu; Richard Kiptum Kurgat; Judith Kusimba Chemuliti; Raymond Ellie Mdachi
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.